Veoza vs Lynkuet: Tracking Guide for Non-Hormonal Menopause Treatments

Veoza (fezolinetant) and Lynkuet (elinzanetant) are both non-hormonal medications for menopause hot flashes. If you're comparing these options, tracking your symptoms helps inform the decision with your healthcare provider.

Key differences at a glance

| Feature | Veoza (fezolinetant) | Lynkuet (elinzanetant) | |---------|---------------------|------------------------| | Mechanism | NK3 receptor antagonist | NK1 + NK3 dual antagonist | | Primary target | Hot flashes | Hot flashes + sleep | | Dosing | Once daily | Once daily | | Type | Non-hormonal | Non-hormonal |

Both medications are non-hormonal alternatives to HRT for managing vasomotor symptoms.

Why mechanism matters for tracking

Veoza (NK3 only): Blocks the NK3 receptor in the brain's temperature center. Tracking focuses primarily on hot flash reduction.

Lynkuet (NK1 + NK3): Blocks both NK1 and NK3 receptors. The dual mechanism may provide additional benefits for sleep quality. Tracking should capture both hot flashes and sleep metrics.

What to track when comparing options

If considering both treatments

Before your clinician visit, establish baseline data:

Vasomotor symptoms:

• Daily hot flash frequency
• Hot flash severity (consistent 1-5 scale)
• Night sweat count
• Time of day patterns

Sleep quality:

• Hours slept
• Number of wake-ups
• Sleep quality rating (1-10)
• Morning energy level

Quality of life:

• Daily function impact
• Mood and energy
• Work/social limitations

Decision-relevant questions

Your tracking can help answer:

• Are hot flashes my primary concern, or is sleep equally problematic?
• Do night symptoms disrupt sleep more than day symptoms?
• What's my current sleep quality baseline?
• Which symptoms most impact my quality of life?

If you're switching between treatments

When transitioning from one to the other:

1. Document final state on first treatment:

   • Hot flash frequency achieved
   • Sleep quality at end of treatment
   • Any remaining concerns

2. Track transition period:

   • Any washout symptoms
   • Timeline to notice new medication effects

3. Compare apples to apples:

   • Same tracking metrics before and after
   • Similar time periods for comparison

Tracking template for comparison

Baseline (before any treatment)

Hot flashes:

• Average daily count: ___
• Worst severity: ___
• Night sweats per night: ___

Sleep:

• Hours per night: ___
• Wake-ups: ___
• Quality (1-10): ___

Week 4 Assessment

Hot flashes:

• Average daily count: ___
• Percent change from baseline: ___%
• Night sweats per night: ___

Sleep:

• Hours per night: ___
• Wake-ups: ___
• Quality (1-10): ___
• Change from baseline: ___

Questions for your clinician conversation

Bring your tracking data to discuss:

• Given my hot flash frequency and severity, which approach fits better?
• How important is my sleep data in this decision?
• What monitoring requirements differ between options?
• Based on my symptom pattern, what does evidence suggest?

Both vs. hormone therapy

If you're comparing non-hormonal options to HRT:

Why someone might choose non-hormonal:

• Contraindications to hormone therapy
• Personal preference to avoid hormones
• Specific concerns about HRT risks
• Hot flashes as primary symptom (vs. multiple symptoms)

What tracking reveals:

• Whether hot flashes are isolated or part of broader symptom picture
• Sleep issues that may benefit from targeted treatment
• Overall symptom burden to address

Frequently asked questions

Which medication is more effective?

Both showed significant hot flash reduction in clinical trials. Individual response varies. Your tracking data will show how you personally respond.

Can I try one and switch to the other?

Treatment sequencing is a conversation with your healthcare provider. Tracking data from one treatment helps inform whether a change makes sense.

Do they have different side effects?

Both have some gastrointestinal and other reported effects. Your side effect tracking on either medication provides personalized data for decision-making.

What this page is / is not

This page provides tracking guidance for comparing non-hormonal menopause treatments. It does not recommend one medication over another. Consult your healthcare provider for personalized treatment decisions.